Travoprost is a prostaglandin analog indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. It is available as eye drops, ophthalmic solution and implants for intracameral use. MedsAcross supplies Travoprost for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
From the regulator-approved product information. Each section names its source.
TRAVATAN Z ® (travoprost ophthalmic solution) 0.004% is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. TRAVATAN Z is a prostaglandin analog indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension
Source: US FDA prescribing information
Travoprost free acid, a prostaglandin analog is a selective FP prostanoid receptor agonist, which is believed to reduce IOP by increasing uveoscleral outflow. The exact mechanism of action is unknown at this time.
Source: US FDA prescribing information
The recommended dosage is one drop in the affected eye(s) once daily in the evening. TRAVATAN Z should not be administered more than once daily since it has been shown that more frequent administration of prostaglandin analogs may decrease the IOP-lowering effect. Reduction of the IOP starts approximately 2 hours after the first administration with maximum effect reached after 12 hours. TRAVATAN Z may be used concomitantly with other topical ophthalmic drug products to lower IOP. If more than one topical ophthalmic drug is being used, the drugs should be administered at least 5 minutes apart. One drop in the affected eye(s) once daily in the evening
Source: US FDA prescribing information
None. None
Source: US FDA prescribing information
• Pigmentation: Pigmentation of the iris, periorbital tissue (eyelid), and eyelashes can occur. Iris pigmentation likely to be permanent. • Eyelash Changes: Gradual change to eyelashes including increased length, thickness and number of lashes. Usually reversible
Source: US FDA prescribing information
Most common adverse reaction (30% to 50%) is conjunctival hyperemia
Source: US FDA prescribing information
Store at 2°C to 25°C (36°F to 77°F).
Source: US FDA prescribing information
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
5 presentations of Travoprost, sorted by availability.
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Travoprost 0.04 mg/mL eye dropsOphthalmicGeneric name | — | US FDA | Available on request |
| Travoprost 0.04 mg/mL ophthalmic solutionOphthalmicGeneric name | — | US FDA | Available on request |
| Travatan Z 0.04 mg/mL eye dropsOphthalmic | Sandoz | US FDA | Available on request |
| Travoprost Ophthalmic Soluton 0.04 mg/mL eye dropsOphthalmic | Sagent Pharmaceuticals | US FDA | Available on request |
| iDose TR 75 mcg implantIntracameral | Glaukos | US FDA | Available on request |
3 brand names across 1 markets.
United States
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
Conditions linked to Travoprost in public data. This is not a list of approved uses, see the clinical information.
Yes, on request. MedsAcross lists 5 presentations of Travoprost and sources them for licensed hospitals, importers and physicians against valid import documents.
The catalogue lists 3 brand names for Travoprost, including iDose TR, Travatan Z, Travoprost Ophthalmic Soluton.
Yes. The US FDA first approved Travoprost on 16 March 2001, according to Drugs@FDA.
Yes. Travoprost has a central EU marketing authorisation (status: authorised), according to European Medicines Agency data.
No listed presentation of Travoprost is recorded as needing a cold chain. Storage conditions are shown on each presentation page.
Travoprost is classified under ATC code S01EE04 (Travoprost).
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.